Geron Corporation (NASDAQ:GERN) witnessed volume of 9.87 million shares during last trade however it holds an average trading capacity of 1.28 million shares. GERN last trade opened at $1.75 reached intraday low of $1.60 and went -20.45% down to close at $1.75.
Read Full Article and Disclaimer at:http://stockblizzard.com/7458/business-news/strange-volume-of-geron-corp...
GERN, CLNO, LULU, OPXA, - StockHotTips.com Stock Report!
Geron Corporation (Nasdaq:GERN) announced that management will present a company overview upcoming investor conference; UBS Global Life Sciences Conference in New York City. Hoyoung Huh, M.D., Ph.D., Geron's Executive Chairman, and Stephen M. Kelsey, M.D., Executive Vice President, Head of Research & Development and Chief Medical Officer will present at 10:30 a.m.
(GERN, EVCA, BEAT, ORFG, SNBC) Stock Review From PennyOmega.com
GERN, ONNN, OXGN, DIS, - Geron, ON Semiconductor, Oxigene and Walt Disney Stock Report! From CRWESelect.com
Geron Corporation (NASDAQ:GERN) previously announced the publication of preclinical data demonstrating that the company’s telomerase inhibitor drug, imetelstat (GRN163L), currently in Phase 2 clinical trials, targets cancer stem cells from multiple myeloma, pancreatic and breast cancers.